[med-svn] [Git][med-team/q2-fragment-insertion][master] 3 commits: Upload.
Steffen Möller (@moeller)
gitlab at salsa.debian.org
Sat Dec 4 20:09:42 GMT 2021
Steffen Möller pushed to branch master at Debian Med / q2-fragment-insertion
Commits:
f061a9be by Steffen Moeller at 2021-09-26T21:00:04+02:00
Upload.
- - - - -
3beac789 by Steffen Moeller at 2021-12-04T20:56:48+01:00
Added copyright info for versioneer.py.
- - - - -
63c1aad6 by Steffen Moeller at 2021-12-04T21:09:26+01:00
Commenting on failed attempt to sub versioneer.py
- - - - -
3 changed files:
- debian/changelog
- debian/control
- debian/copyright
Changes:
=====================================
debian/changelog
=====================================
@@ -1,6 +1,6 @@
-q2-fragment-insertion (2021.8.0-1) UNRELEASED; urgency=medium
+q2-fragment-insertion (2021.8.0-3) unstable; urgency=medium
* Initial release (Closes: #977115)
- * New upstream version
+ * Reupload after adding copyright info for versioneer.
- -- Steffen Moeller <moeller at debian.org> Wed, 22 Sep 2021 14:54:28 +0200
+ -- Steffen Moeller <moeller at debian.org> Sun, 26 Sep 2021 20:57:50 +0200
=====================================
debian/control
=====================================
@@ -7,7 +7,7 @@ Build-Depends: debhelper-compat (= 13),
dh-python,
python3,
python3-setuptools,
- qiime (>= 2020.11.0),
+ qiime (>= 2021.8.0),
python3-pytest <!nocheck>,
python3-pytest-cov <!nocheck>,
python3-biom-format <!nocheck>,
=====================================
debian/copyright
=====================================
@@ -1,11 +1,16 @@
Format: https://www.debian.org/doc/packaging-manuals/copyright-format/1.0/
Upstream-Name: QIIME 2
Source: https://github.com/qiime2/q2-fragment-insertion
+#Files-Excluded: verioneer.py # does not work.
Files: *
Copyright: 2016-2019 QIIME 2 development team
License: BSD-3-clause
+Files: versioneer.py
+Copyright: Brian Warner
+License: CC0-1.0
+
Files: debian/*
Copyright: 2019-2020 Liubov Chuprikova <chuprikovalv at gmail.com>
Andreas Tille <tille at debian.org>
@@ -57,3 +62,124 @@ License: GPL-2+
.
On a Debian system, the GNU GPL license version 2 is distributed in the
file /usr/share/common-licenses/GPL-2.
+
+License: CC0-1.0
+ From https://creativecommons.org/publicdomain/zero/1.0/
+ .
+ CREATIVE COMMONS CORPORATION IS NOT A LAW FIRM AND DOES NOT PROVIDE
+ LEGAL SERVICES. DISTRIBUTION OF THIS DOCUMENT DOES NOT CREATE AN
+ ATTORNEY-CLIENT RELATIONSHIP. CREATIVE COMMONS PROVIDES THIS INFORMATION
+ ON AN "AS-IS" BASIS. CREATIVE COMMONS MAKES NO WARRANTIES REGARDING THE
+ USE OF THIS DOCUMENT OR THE INFORMATION OR WORKS PROVIDED HEREUNDER,
+ AND DISCLAIMS LIABILITY FOR DAMAGES RESULTING FROM THE USE OF THIS
+ DOCUMENT OR THE INFORMATION OR WORKS PROVIDED HEREUNDER.
+ .
+ Statement of Purpose
+ .
+ The laws of most jurisdictions throughout the world automatically confer
+ exclusive Copyright and Related Rights (defined below) upon the creator
+ and subsequent owner(s) (each and all, an "owner") of an original work
+ of authorship and/or a database (each, a "Work").
+ .
+ Certain owners wish to permanently relinquish those rights to a Work
+ for the purpose of contributing to a commons of creative, cultural and
+ scientific works ("Commons") that the public can reliably and without
+ fear of later claims of infringement build upon, modify, incorporate in
+ other works, reuse and redistribute as freely as possible in any form
+ whatsoever and for any purposes, including without limitation commercial
+ purposes. These owners may contribute to the Commons to promote the ideal
+ of a free culture and the further production of creative, cultural and
+ scientific works, or to gain reputation or greater distribution for
+ their Work in part through the use and efforts of others.
+ .
+ For these and/or other purposes and motivations, and without any
+ expectation of additional consideration or compensation, the person
+ associating CC0 with a Work (the "Affirmer"), to the extent that
+ he or she is an owner of Copyright and Related Rights in the Work,
+ voluntarily elects to apply CC0 to the Work and publicly distribute
+ the Work under its terms, with knowledge of his or her Copyright and
+ Related Rights in the Work and the meaning and intended legal effect
+ of CC0 on those rights.
+ .
+ 1. Copyright and Related Rights. A Work made available under CC0
+ may be protected by copyright and related or neighboring rights
+ ("Copyright and Related Rights"). Copyright and Related Rights
+ include, but are not limited to, the following:
+ .
+ i the right to reproduce, adapt, distribute, perform, display,
+ communicate, and translate a Work;
+ ii moral rights retained by the original author(s) and/or performer(s);
+ iii publicity and privacy rights pertaining to a person's image or
+ likeness depicted in a Work;
+ iv rights protecting against unfair competition in regards to a Work,
+ subject to the limitations in paragraph 4(a), below;
+ v rights protecting the extraction, dissemination, use and reuse of data in a Work;
+ vi database rights (such as those arising under Directive 96/9/EC of the
+ European Parliament and of the Council of 11 March 1996 on the legal
+ protection of databases, and under any national implementation thereof,
+ including any amended or successor version of such directive); and
+ vii other similar, equivalent or corresponding rights throughout the world
+ based on applicable law or treaty, and any national implementations
+ thereof.
+ .
+ 2. Waiver. To the greatest extent permitted by, but not in
+ contravention of, applicable law, Affirmer hereby overtly, fully,
+ permanently, irrevocably and unconditionally waives, abandons,
+ and surrenders all of Affirmer's Copyright and Related Rights and
+ associated claims and causes of action, whether now known or unknown
+ (including existing as well as future claims and causes of action),
+ in the Work (i) in all territories worldwide, (ii) for the maximum
+ duration provided by applicable law or treaty (including future time
+ extensions), (iii) in any current or future medium and for any number
+ of copies, and (iv) for any purpose whatsoever, including without
+ limitation commercial, advertising or promotional purposes (the
+ "Waiver"). Affirmer makes the Waiver for the benefit of each member
+ of the public at large and to the detriment of Affirmer's heirs and
+ successors, fully intending that such Waiver shall not be subject to
+ revocation, rescission, cancellation, termination, or any other legal
+ or equitable action to disrupt the quiet enjoyment of the Work by
+ the public as contemplated by Affirmer's express Statement of Purpose.
+ .
+ 3. Public License Fallback. Should any part of the Waiver for any
+ reason be judged legally invalid or ineffective under applicable law,
+ then the Waiver shall be preserved to the maximum extent permitted
+ taking into account Affirmer's express Statement of Purpose. In
+ addition, to the extent the Waiver is so judged Affirmer hereby
+ grants to each affected person a royalty-free, non transferable, non
+ sublicensable, non exclusive, irrevocable and unconditional license
+ to exercise Affirmer's Copyright and Related Rights in the Work (i)
+ in all territories worldwide, (ii) for the maximum duration provided
+ by applicable law or treaty (including future time extensions), (iii)
+ in any current or future medium and for any number of copies, and (iv)
+ for any purpose whatsoever, including without limitation commercial,
+ advertising or promotional purposes (the "License"). The License
+ shall be deemed effective as of the date CC0 was applied by Affirmer
+ to the Work. Should any part of the License for any reason be judged
+ legally invalid or ineffective under applicable law, such partial
+ invalidity or ineffectiveness shall not invalidate the remainder
+ of the License, and in such case Affirmer hereby affirms that he or
+ she will not (i) exercise any of his or her remaining Copyright and
+ Related Rights in the Work or (ii) assert any associated claims and
+ causes of action with respect to the Work, in either case contrary
+ to Affirmer's express Statement of Purpose.
+ .
+ 4. Limitations and Disclaimers.
+ .
+ No trademark or patent rights held by Affirmer are waived, abandoned,
+ surrendered, licensed or otherwise affected by this document.
+ Affirmer offers the Work as-is and makes no representations or
+ warranties of any kind concerning the Work, express, implied,
+ statutory or otherwise, including without limitation warranties
+ of title, merchantability, fitness for a particular purpose, non
+ infringement, or the absence of latent or other defects, accuracy,
+ or the present or absence of errors, whether or not discoverable,
+ all to the greatest extent permissible under applicable law.
+ Affirmer disclaims responsibility for clearing rights of other
+ persons that may apply to the Work or any use thereof, including
+ without limitation any person's Copyright and Related Rights in the
+ Work. Further, Affirmer disclaims responsibility for obtaining any
+ necessary consents, permissions or other rights required for any
+ use of the Work.
+ Affirmer understands and acknowledges that Creative Commons is not
+ a party to this document and has no duty or obligation with respect
+ to this CC0 or use of the Work.
View it on GitLab: https://salsa.debian.org/med-team/q2-fragment-insertion/-/compare/12ebb788747c2b565b7fbe20032ad091c1efe463...63c1aad6ad941b49bd00fc7007f3cbc2ecdce953
--
View it on GitLab: https://salsa.debian.org/med-team/q2-fragment-insertion/-/compare/12ebb788747c2b565b7fbe20032ad091c1efe463...63c1aad6ad941b49bd00fc7007f3cbc2ecdce953
You're receiving this email because of your account on salsa.debian.org.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://alioth-lists.debian.net/pipermail/debian-med-commit/attachments/20211204/b57b59a1/attachment-0001.htm>
More information about the debian-med-commit
mailing list